Skip to main content

Articles

Original Research, Practice Management
Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015
Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD
Stakeholder Perspective
The Importance and Benefits of Smoking-Cessation Therapy
Jack E. Fincham, PhD, RPh
Read More
Original Research, Practice Management
Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies
Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh
Read More
IDWeek 2018
Health-Related Social Vulnerabilities in a Pediatric Outpatient Antimicrobial Therapy Program
Read More
IDWeek 2018
The AMMO Study: Antimicrobial Management in Extracorporeal Membrane Oxygenation
Read More
IDWeek 2018
Systematic Review and Network Meta-Analysis of Randomized Trials of Antibiotic Therapy for Community-Acquired Pneumonia
Read More
IDWeek 2018
LEAP 2 Study Shows Oral Lefamulin Is Safe and Effective in Treatment of Adults with Community-Acquired Bacterial Pneumonia
Read More
IDWeek 2018
Pooled Analysis of Safety Data from Phase 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections
Read More
IDWeek 2018
Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic
Read More
IDWeek 2018
Antimicrobial Stewardship Program Aims to Reduce Antimicrobial Usage in Geriatric Patients without Affecting Outcomes
Read More
IDWeek 2018
Longer Duration of Antibiotic Therapy for Community-Acquired Pneumonia and Risk for Clostridium Difficile Infection
Read More
Page 65 of 244
Results 641 - 650 of 2434